Company: CI
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001739940-25-000021
Chunk: 54

Company: Cigna Group
Filing Date: 2025-05-02
Form: 10-Q
Item: Part I, Item 1
Chunk 54
---
 a better future for every individual and every community. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental, and related products and services. For further information on our business and strategy, see Part I, Item 1 - "Business" in our 2024 Form 10-K. 

Financial Highlights

Consolidated Results of Operations (GAAP basis)Three Months Ended March 31,(Dollars in millions)20252024ChangePharmacy revenues$48,633 $42,036 16 %Premiums12,736 11,603 10 Fees and other revenues3,895 3,326 17 Net investment income238 290 (18)Total revenues65,502 57,255 14 Pharmacy and other service costs48,398 41,431 17 Medical costs and other benefit expenses10,498 9,440 11 Selling, general and administrative expenses4,213 3,705 14 Amortization of acquired intangible assets422 423 — Total benefits and expenses63,531 54,999 16 Income from operations1,971 2,256 (13)Interest expense and other(362)(322)12 Gain (loss) on sale of businesses41 (19)N/MNet investment losses(2)(1,836)(100)Income before income taxes1,648 79 N/MTotal income taxes239 291 (18)Net income (loss)1,409 (212)N/MLess: Net income attributable to noncontrolling interests86 65 32 Shareholders' net income (loss)$1,323 $(277)N/M%Consolidated effective tax rate14.5 %368.4 %N/MbpsMedical customers (in thousands)18,043 19,184 (6)%

31

Reconciliation of Shareholders' Net Income (Loss) (GAAP) to Adjusted Income from OperationsThree Months Ended March 31,20252024(In millions)Pre-taxAfter-taxPre-taxAfter-taxShareholders' net income (loss)$1,323 $(277)Adjustments to reconcile to adjusted income from operationsNet investment (gains) losses (1)$(48)(48)$1,828 1,827 Amortization of acquired intangible assets422 336 423 322 Special itemsIntegration and transaction-related costs216 164